Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLO test results

16 Sep 2009 07:30

RNS Number : 1252Z
T2 Income Fund Limited
16 September 2009
 

T2 Income Fund Limited ("T2" or the "Company")

Monthly CLO Test Results

The Company announces the test results as of 2 September 2009 pursuant to the indenture of the Company's subsidiary, T2 Income Fund CLO I Ltd (the "CLO"). The report summarising the results of those tests can be found at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1252Z_-2009-9-15.pdf

With respect to the various tests required under the CLO indenture, on 14 September 2009, the CLO passed all collateral coverage tests and all of the loans held within the CLO continue to pay the interest due. 

It should be noted that the implications of failing the collateral coverage tests are very complicated, and the consequences could include interest diversion, principal repayment, or limitations on reinvestment of available cash balances. 

Distinct from the collateral coverage tests are the percentage limitation tests. The consequence of failing these percentage limitation tests is simply that each new investment made by the CLO must "maintain or improve" the test result.

The CLO failed four portfolio percentage limitation tests, two of which relate to limitations on loans rated CCC+/Caa1 and lower by S&P and Moody's, respectively, one related to the highest single obligor for non-senior secured loans and one related to the minimum percentage of senior secured loans required to be outstanding.

The failure of the senior secured loan minimum percentage was due to the amount of cash held within the CLO ($32.1 million); cash is excluded when calculating the percentage of senior secured loans. The Company believes that the substantial cash balance provides an opportunity to acquire better-rated securities at discounts to their par value, which should help to improve the quality of the portfolio as well as improve the CLO's collateral test coverage ratios under a variety of scenarios. As cash is invested in new senior secured loans, this failure should be cured automatically. Although no new investments rated CCC+/Caa1 or lower have been made by the manager for some time, the failure of CCC+/Caa1 percentage limitations tests occurred due to historic and ongoing downgrades of companies by S&P and Moody's. The manager continues to evaluate opportunities to reduce the amount of these loans in situations where a sale could be achieved without incurring substantial principal losses.

The failure of the highest single obligor for non-senior secured ("second lien") loans percentage was due to the sale of certain loans at the CLO's option in August , due to credit concerns, at a realized loss, which reduced the aggregate collateral balance from approximately $303 million in July 2009 to $297 million in August 2009. Since there is a single non-senior secured loan of $9.0 million currently outstanding, the 3.0% maximum limit percentage was violated. However, this specific test is a "maintain and improve" covenant and thus does result in interest diversion or principal paydown.

These covenant violations described above do not have a material impact on the CLO's ability to invest in new loans, and all of the loans held within the CLO continue to pay the interest due.

The next payment test date is 2 October 2009. While we continue to monitor the situation closely, we currently have only limited visibility with respect to which of the CLO tests may or may not be met on that date or other future dates, and whether any further principal paydowns or interest diversions may occur and, if so, the magnitude of those paydowns or diversions.  

While the current month's test results are not controlling as to the 2 October 2009 payment test, it may be worth noting that, had this been a payment test, there would not have been an interest diversion.

As described in previous press releases, the CLO indenture contains a variety of covenants, compliance with which could be made more difficult or impossible should credit markets deteriorate or the loans held by the CLO fail to make expected payments or otherwise not perform.

Contacts:

Geoffrey MillerT2 Income Fund Limited+353 1 4433 466

Patrick ConroyT2 Income Fund Limited+1 203 983 5282

Philip SecrettNominated AdviserGrant Thornton UK LLP+44 (0) 20 7383 5100

Jos TrustedSinger Capital Markets Limited +44 (0) 20 3205 7622

Ed Gascoigne PeesFinancial Dynamics+44 (0) 20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFFFLASIELIA
Date   Source Headline
23rd Sep 20147:00 amRNSHalf Yearly Report
19th Sep 20142:55 pmRNSSharedealing
17th Sep 20147:00 amRNSAdditional Listing
16th Sep 20147:00 amRNSEmma Stubbs appointment
5th Sep 20147:00 amRNSNotice of Results
18th Aug 20147:00 amRNSNAV and Trading Update
16th Jul 20147:00 amRNS2014 Second Interim Dividend
20th Jun 20145:25 pmRNSHolding(s) in Company
20th Jun 20147:00 amRNSDirector/PDMR Shareholding
19th Jun 20147:00 amRNSAdditional Listing
12th Jun 20147:00 amRNSDisposal of CLO investments
19th May 20147:00 amRNSAgreement to Dispose of CLO investments
6th May 20147:01 amRNSDirector/PDMR Shareholding
2nd May 20145:00 pmRNSDirector/PDMR Shareholding
30th Apr 20144:56 pmRNSResult of AGM
30th Apr 20147:00 amRNSAGM Statement
24th Apr 20147:00 amRNSDividend Declaration
24th Apr 20147:00 amRNSNet Asset Value(s)
4th Apr 20143:16 pmRNSAnnual Financial Report
26th Mar 20147:00 amRNSFinal Results
24th Mar 20147:00 amRNSNotice of Results
20th Mar 20141:48 pmRNSDirector/PDMR Shareholding
19th Mar 201412:51 pmRNSAdditional Listing
6th Mar 20147:00 amRNS2013 Fourth Interim Dividend - Timetable amendment
26th Feb 201412:11 pmRNSHolding(s) in Company
19th Feb 20141:29 pmRNSHolding(s) in Company
29th Jan 201411:34 amRNSHolding(s) in Company
24th Jan 20144:45 pmRNSDirector/PDMR Shareholding
24th Jan 201412:00 pmRNSDirector/PDMR Shareholding
22nd Jan 201412:10 pmRNSDirector/PDMR Shareholding
22nd Jan 20147:00 amRNSNAV and Trading Update
21st Jan 20147:00 amRNSDividend Declaration
9th Dec 201312:46 pmRNSCancellation of listing from CISX
5th Dec 201311:30 amRNSResult of EGM
5th Dec 20138:00 amRNSDirector/PDMR Shareholding
4th Dec 20133:00 pmRNSSCRIP DIVIDEND - ADDITIONAL LISTING
13th Nov 201311:00 amRNSInvesting policy / Cancellation CISX listing / EGM
6th Nov 201311:00 amRNSHolding(s) in Company
4th Nov 20132:00 pmRNSHolding(s) in Company
29th Oct 20134:30 pmRNSHolding(s) in Company
29th Oct 20134:00 pmRNSChange of Adviser
24th Oct 20137:00 amRNSNAV and Trading Update
21st Oct 201312:45 pmRNSResult of EGM
9th Oct 20137:00 amRNSDividend Declaration
3rd Oct 201311:30 amRNSPublication of circular and General Meeting
1st Oct 20137:00 amRNSResults of Placing
30th Sep 20138:01 amRNSIssue of Equity
30th Sep 20137:00 amRNSInterim Results
24th Sep 20132:00 pmRNSHolding(s) in Company
19th Sep 20133:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.